225 related articles for article (PubMed ID: 24742286)
1. Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice.
Wu Y; Kim J; Elshimali Y; Sarkissyan M; Vadgama JV
BMC Cancer; 2014 Apr; 14():266. PubMed ID: 24742286
[TBL] [Abstract][Full Text] [Related]
2. Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.
Blanco-Aparicio C; Pérez-Gallego L; Pequeño B; Leal JF; Renner O; Carnero A
Carcinogenesis; 2007 Mar; 28(3):584-94. PubMed ID: 17050554
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
Mancini ML; Lien EC; Toker A
Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
[TBL] [Abstract][Full Text] [Related]
4. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
[TBL] [Abstract][Full Text] [Related]
5. Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5.
Xiang S; Mao L; Yuan L; Duplessis T; Jones F; Hoyle GW; Frasch T; Dauchy R; Blask DE; Chakravarty G; Hill SM
J Pineal Res; 2012 Oct; 53(3):307-18. PubMed ID: 22582905
[TBL] [Abstract][Full Text] [Related]
6. Delayed mammary gland involution in MMTV-AKT1 transgenic mice.
Ackler S; Ahmad S; Tobias C; Johnson MD; Glazer RI
Oncogene; 2002 Jan; 21(2):198-206. PubMed ID: 11803463
[TBL] [Abstract][Full Text] [Related]
7. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
8. The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.
Tomblyn S; Langenheim JF; Jacquemart IC; Holle E; Chen WY
Int J Oncol; 2005 Nov; 27(5):1381-9. PubMed ID: 16211235
[TBL] [Abstract][Full Text] [Related]
9. Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode.
Luque RM; Villa-Osaba A; L-López F; Pozo-Salas AI; Sánchez-Sánchez R; Ortega-Salas R; de Lecea L; Álvarez-Benito M; López-Miranda J; Gahete MD; Castaño JP
Breast Cancer Res; 2016 Mar; 18(1):29. PubMed ID: 26956474
[TBL] [Abstract][Full Text] [Related]
10. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
11. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
12. Maternal flaxseed diet during pregnancy or lactation increases female rat offspring's susceptibility to carcinogen-induced mammary tumorigenesis.
Khan G; Penttinen P; Cabanes A; Foxworth A; Chezek A; Mastropole K; Yu B; Smeds A; Halttunen T; Good C; Mäkelä S; Hilakivi-Clarke L
Reprod Toxicol; 2007; 23(3):397-406. PubMed ID: 17398067
[TBL] [Abstract][Full Text] [Related]
13. Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice.
Li B; Chi X; Song J; Tang Y; Du J; He X; Sun X; Bi Z; Wang Y; Zhan J; Zhang H
Sci China Life Sci; 2019 Feb; 62(2):225-234. PubMed ID: 30460471
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
15. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
[TBL] [Abstract][Full Text] [Related]
17. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
Crowley MR; Frost A; Chen DT; Baffi MO; Nicola T; Serra R
Differentiation; 2006 Feb; 74(1):40-52. PubMed ID: 16466399
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia.
Schroeder JA; Lee DC
J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):119-29. PubMed ID: 10882298
[TBL] [Abstract][Full Text] [Related]
20. Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.
Hoshino A; Yee CJ; Campbell M; Woltjer RL; Townsend RL; van der Meer R; Shyr Y; Holt JT; Moses HL; Jensen RA
Int J Biol Sci; 2007 Apr; 3(5):281-91. PubMed ID: 17505536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
